Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

<i><scp>FGFR</scp></i> gene alterations in lung squamous cell carcinoma are potential targets for the multikinase inhibitor nintedanib

1 Sept 2016

Abstract excerpt

Fibroblast growth factor receptor (FGFR) gene alterations are relatively frequent in lung squamous cell carcinoma (LSCC) and are a potential targets for therapy with FGFR inhibitors. However, little is known regarding the clinicopathologic features associated with FGFR alterations. The angiokinase inhibitor nintedanib has shown promising activity in clinical trials for non-small cell lung cancer. We have now...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Fibroblast Growth Factor Research
Share to Lung Cancer Treatments and Mutations
Share to Tuberous Sclerosis Complex Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27581340
DOI: 10.1111/cas.13071

Provenance

PubMed metadata and Literature Corpus relationships.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

<i><scp>FGFR</scp></i> gene alterations in lung squamous cell carcinoma are potential targets for the multikinase inhibitor nintedanibPMID 27581340Read ↗

Inhibitor-Sensitive FGFR1 Amplification in Human Non-Small Cell Lung CancerSemantic proximity Read ↗

Inhibitor-sensitive FGFR2 and FGFR3 mutations in lung squamous cell carcinoma.Semantic proximity Read ↗

Role of FGF Receptors as an Emerging Therapeutic Target in Lung Squamous Cell CarcinomaSemantic proximity Read ↗

[Progress on the Study of Targeting FGFR in Squamous Non-small Cell Lung Cancer].Semantic proximity Read ↗

Detection of Known and Novel FGFR Fusions in Non–Small Cell Lung Cancer by Comprehensive Genomic ProfilingSemantic proximity Read ↗

Clinical advances and challenges in targeting FGF/FGFR signaling in lung cancerSemantic proximity Read ↗

Fibroblast Growth Factor Receptor 1-4 Genetic Aberrations as Clinically Relevant Biomarkers in Squamous Cell Lung CancerSemantic proximity Read ↗

FGFR1 is a Potential Therapeutic Target in NeuroblastomaSemantic proximity Read ↗

Mutational analysis of EGFR and related signaling pathway genes in lung adenocarcinomas identifies a novel somatic kinase domain mutation in FGFR4.Semantic proximity Read ↗

The FGFR Landscape in Cancer: Analysis of 4,853 Tumors by Next-Generation Sequencing.Semantic proximity Read ↗

Acquired nintedanib resistance in FGFR1-driven small cell lung cancer: role of endothelin-A receptor-activated ABCB1 expression.Semantic proximity Read ↗

Role of novel cancer gene SLITRK3 to activate NTRK3 in squamous cell lung cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.